Carnitine deficiency, organic acidemias, and reye’s syndrome

David A. Stumpf, W. Davis Parker, Corrado Angelini

Research output: Contribution to journalArticle

Abstract

Relative carnitine deficiency is important in the pathophysiology of several disorders, including Reye’s syndrome and organic acidemias. In acute clinical crises, carnitine serves as a “buffer,” trapping toxic acyl compounds. Mitochondrial failure develops in carnitine deficiency when there is insufficient tissue carnitine available to buffer toxic acyl-CoA metabolites. Toxic levels of acyl-Co A impair the citrate cycle, gluconeogenesis, the urea cycle, and fatty-acid oxidation. Carnitine replacement therapy is safe and induces excretion of toxic acyl groups in the urine.

Original languageEnglish
Pages (from-to)1041-1045
Number of pages5
JournalNeurology
Volume35
Issue number7
Publication statusPublished - 1985

    Fingerprint

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Stumpf, D. A., Parker, W. D., & Angelini, C. (1985). Carnitine deficiency, organic acidemias, and reye’s syndrome. Neurology, 35(7), 1041-1045.